Question special
Lead Moderator

It's clearly important to define optimal medical therapy in patients with PAD but some would say worrying about ticagrelor versus clopidogrel is an academic point given that compliance with even more basic principles of therapy - statins, antiplatelet of any kind, and so forth - is so poor as shown by PREVENT III, for example. The fault for this may lie in some part with patients but also with those who take care of these patients. What can be done to better improve compliance, both from physicians and patients? Is this just a systems issue that can be attacked with a better electronic medical records system or is there something deeper at work? Expert vascular surgeons, in particular, what are your thoughts and experiences?